RxDoctor Payments Data

Harvey Gutman

Urology · Smithtown, NYNPI 1427004175

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.5% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Johnson & Johnson at 33.7% of the total. Reporting peaked in 2022 at $1,186 and has fallen 84.9% since, to $179 in 2023.

$3,599in general payments, 2019–2025

Across 154 payments — averaging $23.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Astellas Pharma US Inc$455
  • AbbVie$223
  • Endo Pharmaceuticals Inc.$192
  • Pfizer$190
  • Shionogi Inc$173
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,25790%
  • Education$34310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,599 in reported general payments places this provider in the 55th percentile of 952 urology providers in New York.

See all urology providers in New York →

Other urology in Smithtown

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →